Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167140 · ClinicalTrials.gov registry record · Phase 2
Cryo-Touch II for the Treatment of Wrinkles
A Phase 2 study of Facial Wrinkles, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01167140: Completed Phase 2 study of Facial Wrinkles, sponsored by Pacira Pharmaceuticals.
NCT01167140 is a Phase 2 study of Facial Wrinkles that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 42 participants, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01167140, a Phase 2 study of Facial Wrinkles, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.
Primary Outcome
* Effectiveness success: an improvement in line severity in the target area in animation at 30 days post-treatment as rated by the investigator using the 5-point wrinkle scale * Safety success: the absence of a device-related serious adverse event (DSAE)
Conditions Studied
Interventions
- DEVICE Cryo-Touch II
Study Locations (1)
California
- The Aesthetics Research Center - Redwood City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-07 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
What the finished NCT01167140 record still lists
NCT01167140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 80-participant average among 6 other Facial Wrinkles trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Facial Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Cryo-Touch II is the first listed.
NCT01167140 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01167140 about?
NCT01167140 is a clinical study titled "Cryo-Touch II for the Treatment of Wrinkles". This is a prospective, non-randomized study to evaluate the performance of the MyoScience Cryo-Touch II device for the treatment of wrinkles.
What is the current status of trial NCT01167140?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2010-07. Estimated completion is 2011-04.
What conditions does trial NCT01167140 study?
This clinical trial studies the following conditions: Facial Wrinkles.
What interventions are being tested in trial NCT01167140?
The interventions under investigation include: Cryo-Touch II (DEVICE).
Who is sponsoring clinical trial NCT01167140?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01167140 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Wrinkles
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
COMPLETED · Phase 2
-
A 4-Arm Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults
COMPLETED · Phase 2
-
Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles
COMPLETED · NA
-
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
COMPLETED · Phase 3
-
PicoWay™ 730 Resolve Fusion for Benign Pigmented Lesions and Wrinkles
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia